8-K: Monroe Capital to Merge with Horizon Finance After Asset Sale

Monroe Capital Corporation will merge with Horizon Finance Technology following the sale of its investment assets to Monroe Capital Income Plus Corporation.

Summary

• Monroe Capital Corporation (MRCC) has entered into a definitive merger agreement with Horizon Finance Technology (HRZN) and HMMS, Inc. (Merger Sub), a wholly-owned subsidiary of HRZN.
• Immediately prior to the merger, MRCC will sell substantially all of its investment assets to Monroe Capital Income Plus Corporation (MCIP) for cash at fair value.
• The merger will occur in two steps: first, Merger Sub will merge into MRCC, with MRCC continuing as a wholly-owned subsidiary of HRZN; then, MRCC will merge into HRZN, with HRZN as the surviving entity.
• The transactions are structured to comply with Rule 17a-8 of the Investment Company Act of 1940 and are intended to be treated as a reorganization under Section 368(a) of the Internal Revenue Code.
• Each outstanding share of MRCC common stock will be converted into HRZN common stock based on an Exchange Ratio, calculated as MRCC's Net Asset Value (NAV) per share divided by HRZN's NAV per share, determined shortly before the merger.
• No fractional shares of HRZN common stock will be issued; holders will receive cash in lieu of fractional shares based on HRZN's volume-weighted average trading price.
• Horizon Technology Finance Management LLC (HRZN Advisor) has agreed to waive an aggregate of $4.0 million in Base Management Fees and/or Incentive Fees, at a rate of $1.0 million per quarter for four quarters, commencing after the merger closes.
• The boards of directors of MRCC, HRZN, and MCIP, including their respective independent directors and special committees, have unanimously approved the agreements and transactions.

Sentiment

Score: 7

Explanation: The filing announces a strategic merger and asset sale, which are significant corporate actions. The unanimous board approvals and the advisor fee waiver are positive indicators for the transaction's potential success and shareholder value. However, the inherent risks associated with M&A, such as integration challenges and the possibility of competing offers, temper the overall sentiment. The detailed disclosure of termination fees and potential litigation risks also adds a layer of caution.

Positives

• The merger is expected to be in the best interests of both MRCC and HRZN stockholders, with no dilution to existing stockholders' interests as provided under Rule 17a-8 of the Investment Company Act.
• The HRZN Advisor's fee waiver of $4.0 million is a direct financial benefit to the combined entity, potentially enhancing future profitability.
• The transactions are designed to comply with regulatory safe harbor provisions, indicating a structured and compliant approach.

Negatives

• Termination fees are stipulated: approximately $11 million payable by a third-party acquiror to MRCC if HRZN's agreement is terminated for a superior proposal, and approximately $5.4 million payable by a third-party acquiror to HRZN if MRCC's agreement is terminated for a superior proposal.
• MRCC may be required to reimburse MCIP for up to $500,000 in expenses if the Asset Purchase Agreement is terminated under certain conditions.

Risks

• Uncertainty regarding the timing or likelihood of the proposed transactions closing.
• The expected synergies and savings associated with the proposed transactions may not materialize.
• Failure to realize the anticipated benefits of the proposed transactions.
• The possibility that one or more closing conditions may not be satisfied or waived, including governmental entities prohibiting, delaying, or requiring conditions for approval, or required shareholder approvals not being obtained.
• The possibility of competing offers or acquisition proposals emerging.
• Risks related to diverting management's attention from ongoing business operations.
• Potential for shareholder litigation in connection with the proposed transactions, which could result in significant defense costs and liability.
• Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates.
• Risks associated with possible disruption in operations due to terrorism, war, geopolitical conflict, natural disasters, tariffs, or public health crises and epidemics.
• Future changes in laws or regulations, including their interpretation by regulatory authorities.
• Conditions in the operating areas of Business Development Companies (BDCs) or regulated investment companies (RICs).
• No assurance that the market price of HRZN's shares, either absolutely or relative to net asset value, will increase as a result of any share repurchases, or that any repurchase plan will enhance shareholder value over the long term.

Future Outlook

The companies anticipate the transactions will lead to improved operations, enhanced revenues and cash flow, increased growth potential, a stronger market profile, and greater financial strength for the combined entity. HRZN intends to continue at least one significant historic business line of MRCC or use a significant portion of MRCC's historic business assets in a business following the mergers.

Management Comments

• The boards of directors of both MRCC and HRZN, including their respective independent directors (on the recommendation of special committees), have unanimously determined that the Merger Agreement and the contemplated transactions are advisable and in the best interests of their respective companies.
• The boards also unanimously determined that the interests of their existing stockholders will not be diluted as a result of the transactions, as provided under Rule 17a-8 of the Investment Company Act.

Industry Context

This announcement signifies a strategic consolidation within the Business Development Company (BDC) sector. Mergers and acquisitions in this space often aim to achieve greater scale, operational efficiencies, and potentially broader investment capabilities, which can be beneficial in a competitive financial landscape. The fee waiver from HRZN Advisor suggests an alignment of interests to ensure the success of the combined entity post-merger.

Management Changes

Corporate Governance

Legal Proceedings

• No material proceedings are pending or threatened against MRCC or HRZN or their consolidated subsidiaries.
• No material proceedings are pending or threatened with respect to any Purchased Asset.
• Shareholder litigation in connection with the proposed transactions is identified as a potential risk, which could result in significant costs of defense and liability.

Related Party Transactions

• The Asset Purchase Agreement is between MRCC and MCIP, both of which are advised by Monroe Capital BDC Advisors, LLC (Monroe Advisor), indicating a related party transaction.
• The Merger Agreement involves HRZN and HRZN Advisor, with HRZN Advisor agreeing to a fee waiver, which is a transaction between related parties (HRZN and its advisor).

Stakeholder Impact

• Shareholders of MRCC will receive HRZN common stock, potentially benefiting from the scale and synergies of the combined entity.
• Shareholders of HRZN may benefit from the increased asset base and potential operational efficiencies resulting from the merger.
• The fee waiver from HRZN Advisor could positively impact the profitability and net investment income available to HRZN's shareholders.
• Management's attention may be diverted from ongoing business operations due to the complexities of the merger and asset sale.
• Employees of the respective advisors (Monroe Advisor and HRZN Advisor) are involved in the management of the BDCs, and their roles may be impacted by the consolidation and new governance structure.

Next Steps

• HRZN and MRCC will jointly prepare and file a Registration Statement on Form N-14 and a Joint Proxy Statement/Prospectus with the SEC.
• HRZN will use reasonable best efforts to have the Registration Statement declared effective by the SEC.
• The Joint Proxy Statement/Prospectus will be mailed to MRCC and HRZN stockholders.
• MRCC and HRZN will convene stockholder meetings to obtain the necessary approvals for the merger and related matters.
• Required regulatory approvals, including the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, must be obtained.
• HRZN will seek approval for the listing of its common stock (to be issued as merger consideration) on the Nasdaq Global Select Market.
• MRCC will declare and pay a Tax Dividend for all taxable years ending prior to or with the Effective Time.
• Immediately after the Second Merger, HRZN and HRZN Advisor will enter into a fee waiver agreement.
• The HRZN Board will be reconstituted to include an independent member from the MRCC Board.

Key Dates

Recommendation

The filing details a complex strategic transaction involving a merger and an asset sale, which typically carries both significant potential upside from synergies and scale, as well as considerable execution risks. While the unanimous board approvals and the advisor fee waiver are positive signals, the realization of benefits is contingent on successful integration and market conditions. Given the forward-looking nature and the inherent uncertainties of such large-scale corporate actions, a 'hold' recommendation is prudent. Investors should monitor the progress of the approvals, the integration process, and the actualization of anticipated synergies before making further investment decisions.

Keywords

Merger, Acquisition, Asset Sale, Business Development Company, BDC, Investment Company Act, SEC Filing, Corporate Reorganization, Financial Services, Investment Management, Shareholder Approval, Regulatory Approval, Fee Waiver